Dr. David Aaron Fenton is a Farmington, Connecticut based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. David Aaron Fenton is 009812 for Oral and Maxillofacial Surgery in Connecticut. His current practice location is 263 Farmington Ave, Farmington. Patients can reach him at 860-679-2207.
Dr. David Aaron Fenton deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. David Aaron Fenton speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1376704171
NPI Enumeration Date:
24 Jun, 2008
NPI Last Update On:
02 Feb, 2016
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. David Aaron Fenton are as mentioned below.
License Number
Specialization
State
Status
009812
Oral and Maxillofacial Surgery
Connecticut
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
135 Brittany Farms Rd, D New Britain, Connecticut
Zip:
06053-1127
Phone Number:
734-678-8141
Patients can reach Dr. David Aaron Fenton at 263 Farmington Ave, Farmington, Connecticut or can call to book an appointment on 860-679-2207. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.